Sangamo Therapeutics, Inc (SGMO): 8-K filed May 14, 2026

Form type

8-K

Filing date

May 14, 2026

Accession number

0001628280-26-035061

Filer

Sangamo Therapeutics, Inc (CIK 1001233)